Synthesis and biological evaluation of 21-arylidenepregnenolone derivatives as neuroprotective agents. 2012

Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhangjiang High-Tech Park, Shanghai, PR China.

A series of 21-arylidenepregnenolone derivatives and their corresponding epoxides were synthesized. The neuroprotective effects of these steroidal compounds against amyloid-β(25-35) (Aβ(25-35))- and hydrogen peroxide (H(2)O(2))-induced neurotoxicity in PC12 cells, and oxygen-glucose deprivation (OGD)-induced neurotoxicity in SH-SY5Y cells were evaluated. The bioassay results indicated that several 3β-pregn-21-benzylidene-20-one derivatives displayed potent in vitro neuroprotective effects in different screening models, for example, compounds 2b, 3a, 3b, and 3s showing significant activities against Aβ(25-35)-induced neurotoxicity in PC12 cells, 2b showing significant activities against H(2)O(2)-induced neurotoxicity in PC12 cells, and 2g, 3b, and 3e showing potent protection against OGD insult. The results suggested that introduction of an arylidene group into steroidal nucleus played an important role in neuroprotective activity, while the formation of epoxy group at C-5,6 could be also important for the neuroprotective activity in some degree. The pharmacological data reported here are helpful for the design of novel steroidal neuroprotective candidates.

UI MeSH Term Description Entries
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011284 Pregnenolone A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS. 5-Pregnen-3-beta-ol-20-one,5 Pregnen 3 beta ol 20 one
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015687 Cell Hypoxia A condition of decreased oxygen content at the cellular level. Anoxia, Cellular,Cell Anoxia,Hypoxia, Cellular,Anoxia, Cell,Anoxias, Cell,Anoxias, Cellular,Cell Anoxias,Cell Hypoxias,Cellular Anoxia,Cellular Anoxias,Cellular Hypoxia,Cellular Hypoxias,Hypoxia, Cell,Hypoxias, Cell,Hypoxias, Cellular
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid

Related Publications

Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
May 2016, Bioorganic & medicinal chemistry letters,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
October 2019, Molecules (Basel, Switzerland),
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
January 2017, Chemical & pharmaceutical bulletin,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
October 2019, Bioorganic & medicinal chemistry letters,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
December 2020, Bioorganic & medicinal chemistry letters,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
July 2019, MedChemComm,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
June 2009, Bioorganic & medicinal chemistry letters,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
June 2012, Archiv der Pharmazie,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
July 2022, Fitoterapia,
Cheng-Shi Jiang, and Xian-Jun Guo, and Jing-Xu Gong, and Ting-Ting Zhu, and Hai-Yan Zhang, and Yue-Wei Guo
May 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!